News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>UBS Lifts JD HEALTH (06618.HK) TP to $51.5, Rating Buy
UBS released a research report forecasting that JD HEALTH (06618.HK)'s 2Q25 revenue will grow by 17-19% YoY, a high teens incline, implying that 1H25 revenue growth will exceed...
Reset
Send
The window will close in 5 seconds
<Research>UBS Lifts JD HEALTH (06618.HK) TP to $51.5, Rating Buy
Close
Recommend
14
Positive
14
Negative
6
 
SHORT SELL
 
STOCK INFO

UBS released a research report forecasting that JD HEALTH (06618.HK)  +1.600 (+3.505%)    Short selling $42.09M; Ratio 20.827%   's 2Q25 revenue will grow by 17-19% YoY, a high teens incline, implying that 1H25 revenue growth will exceed 20%, beating the market consensus of 18.6%.

Meanwhile, the broker also anticipated that 2Q25 gross profit margin will continue to rise YoY, driven by margin expansion on product sales and strong growth in advertising revenue.

Related NewsM Stanley Raises JD HEALTH (06618.HK) Rev./ Profit Forecasts, Adds TP to $46
UBS raised its 2025-2027 revenue forecasts for JD HEALTH by 2-4%, and its earnings forecasts by 6-9%. The broker also lifted its target price from $45 to $51.5, with rating at Buy.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-17 12:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.